Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier. - Melo-Carrillo, Agustin; Schain, Aaron J.; Stratton, Jennifer; Strassman, Andrew M.; Burstein, Rami (PAIN, 2020)